Terms: = Sarcomas AND PDCD1, CD279, PD-1, PD1, SLEB2, hPD-1, hPD-l, hSLE1 AND Diagnosis
29 results:
1. Immunohistochemistry assessment of tissue neutrophil-to-lymphocyte ratio predicts outcomes in melanoma patients treated with anti-programmed cell death 1 therapy.
Teixeira RJ; de Souza VG; Sorroche BP; Paes VG; Zambuzi-Roberto FA; Pereira CAD; Vazquez VL; Arantes LMRB
Melanoma Res; 2024 Jun; 34(3):234-240. PubMed ID: 38364053
[TBL] [Abstract] [Full Text] [Related]
2. Immune characteristics of dedifferentiated retroperitoneal liposarcomas and the reliability of regional samples in evaluating their tumor immune microenvironments.
Zhou C; Li M; Ren Y; Miao F; Wang Y; Wu T; Gou X; Li W
World J Surg Oncol; 2024 Jan; 22(1):25. PubMed ID: 38254190
[TBL] [Abstract] [Full Text] [Related]
3. Sarcoma in patients with Lynch syndrome and response to immunotherapy.
Shehata MS; Lofftus SY; Park JY; Singh AS; Federman NC; Eilber FC; Crompton JG; McCaw TR
J Surg Oncol; 2024 Mar; 129(4):820-826. PubMed ID: 38151827
[TBL] [Abstract] [Full Text] [Related]
4. diagnosis and management of gastrointestinal SMARCA4-deficient undifferentiated tumors.
Wang J; Elghawy O; Kurpiel B; Kaur V
Clin J Gastroenterol; 2023 Dec; 16(6):807-814. PubMed ID: 37651059
[TBL] [Abstract] [Full Text] [Related]
5. Diagnostic Challenges in pd-1 Inhibitor Induced Panuveitis in a Teenage Girl with Chest Soft Tissue Sarcoma - A Case Report.
Shen Y; Gong Y; Su L
Ocul Immunol Inflamm; 2023 Dec; 31(10):2065-2068. PubMed ID: 37442377
[TBL] [Abstract] [Full Text] [Related]
6. Neurosarcomatous amelanotic transformation of malignant melanoma presenting as malignant periopheral nerve sheath tumor: Rare case report.
Bofan L; Xiaofei X; Jingwen Z; Zuzhuo Z; Tianxiao M; Feng G; Guochuan Z; Zhou Z
Medicine (Baltimore); 2023 Jun; 102(25):e34034. PubMed ID: 37352079
[TBL] [Abstract] [Full Text] [Related]
7. Case report: Targeting the pd-1 receptor and genetic mutations validated in primary histiocytic sarcoma with hemophagocytic lymphohistiocytosis.
Zhao Y; Deng Y; Jiang Y; Zheng W; Tan Y; Yang Z; Wang Z; Xu F; Cheng Z; Yuan L; Peng H
Front Immunol; 2023; 14():1127599. PubMed ID: 36969238
[TBL] [Abstract] [Full Text] [Related]
8. pd-1, PD-L1, NY-ESO-1, and MAGE-A4 expression in cutaneous angiosarcoma: A case report.
Hashimoto K; Nishimura S; Shinyashiki Y; Ito T; Tanaka H; Ohtani K; Kakinoki R; Akagi M
Medicine (Baltimore); 2022 Jul; 101(28):e29621. PubMed ID: 35839046
[TBL] [Abstract] [Full Text] [Related]
9. Clinicopathological characteristics and prognosis of metastatic collecting duct carcinoma.
Zhou L; Liu Y; Mo J; Cui C; Chi Z; Si L; Kong Y; Yan X; Li S; Wu X; Li J; Xu H; Cao D; Guo J; Sheng X
Urol Oncol; 2022 Aug; 40(8):385.e1-385.e8. PubMed ID: 35773144
[TBL] [Abstract] [Full Text] [Related]
10. Primary pleural epithelioid angiosarcoma treated successfully with anti-pd-1 therapy: A rare case report.
Wang X; Wei J; Zeng Z; Cai J; Lu Z; Liu A
Medicine (Baltimore); 2021 Sep; 100(35):e27132. PubMed ID: 34477160
[TBL] [Abstract] [Full Text] [Related]
11. Recent Advances in Pathology: the 2021 Annual Review Issue of The Journal of Pathology.
Herrington CS; Poulsom R; Koeppen H; Coates PJ
J Pathol; 2021 Jul; 254(4):303-306. PubMed ID: 34097314
[TBL] [Abstract] [Full Text] [Related]
12. Targeted therapies and checkpoint inhibitors in sarcoma.
Vasella M; Gousopoulos E; Guidi M; Storti G; Song SY; Grieb G; Pauli C; Lindenblatt N; Giovanoli P; Kim BS
QJM; 2022 Dec; 115(12):793-805. PubMed ID: 33486519
[TBL] [Abstract] [Full Text] [Related]
13. Metastatic Pheochromocytomas and Abdominal Paragangliomas.
Granberg D; Juhlin CC; Falhammar H
J Clin Endocrinol Metab; 2021 Apr; 106(5):e1937-e1952. PubMed ID: 33462603
[TBL] [Abstract] [Full Text] [Related]
14. Case of metastatic kaposi sarcoma successfully treated with anti-pd-1 immunotherapy.
Cesmeci E; Guven DC; Aktas BY; Aksoy S
J Oncol Pharm Pract; 2021 Oct; 27(7):1766-1769. PubMed ID: 33427037
[TBL] [Abstract] [Full Text] [Related]
15. Tertiary lymphoid structures with overlapping histopathologic features of cutaneous marginal zone lymphoma during neoadjuvant cemiplimab therapy are associated with antitumor response.
Sweeney KJ; Tetzlaff MT; Vega F; Gillenwater A; Zuo Z; Gross N; Nagarajan P; Wargo J; Nelson K; Prieto VG; Torres-Cabala CA; Curry JL
J Cutan Pathol; 2021 May; 48(5):674-679. PubMed ID: 33399228
[TBL] [Abstract] [Full Text] [Related]
16. Nivolumab for the Treatment of Advanced Pediatric Malignancies.
MarjaŃska A; Drogosiewicz M; Dembowska-BagiŃska B; PawiŃska-WĄsikowska K; Balwierz W; Bobeff K; MŁynarski W; Mizia-Malarz A; Raciborska A; Wysocki M; StyczyŃski J
Anticancer Res; 2020 Dec; 40(12):7095-7100. PubMed ID: 33288608
[TBL] [Abstract] [Full Text] [Related]
17. Combining BRAF inhibition with oncolytic herpes simplex virus enhances the immune-mediated antitumor therapy of BRAF-mutant thyroid cancer.
Crespo-Rodriguez E; Bergerhoff K; Bozhanova G; Foo S; Patin EC; Whittock H; Buus R; Haider S; Muirhead G; Thway K; Newbold K; Coffin RS; Vile RG; Kim D; McLaughlin M; Melcher AA; Harrington KJ; Pedersen M
J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32759235
[TBL] [Abstract] [Full Text] [Related]
18. A durable complete response to immunotherapy in a patient with metastatic alveolar soft part sarcoma.
Mariuk-Jarema A; Koseła-Paterczyk H; Rogala P; Klimczak A; Wągrodzki M; Maksymiuk B; Rutkowski P
Tumori; 2020 Dec; 106(6):NP9-NP13. PubMed ID: 32567515
[TBL] [Abstract] [Full Text] [Related]
19. Epstein-Barr virus-negative inflammatory pseudotumor-like variant of follicular dendritic cell sarcoma of the liver: A case report and literature review.
Liu X; Cao L; Chin W; Yu J; Liu Y; Zheng S
Clin Res Hepatol Gastroenterol; 2021 Jan; 45(1):101457. PubMed ID: 32540141
[TBL] [Abstract] [Full Text] [Related]
20. Tumor mutation burden and checkpoint immunotherapy markers in primary and metastatic synovial sarcoma.
He M; Abro B; Kaushal M; Chen L; Chen T; Gondim M; Yan W; Neidich J; Dehner LP; Pfeifer JD
Hum Pathol; 2020 Jun; 100():15-23. PubMed ID: 32387103
[TBL] [Abstract] [Full Text] [Related]
[Next]
